$3.64
-0.19 (-4.96%)
Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)
CAPS Rating:
A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.
RSS Headlines
Fool UK